﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Silicon Investor - Oscient Pharmaceuticals Corp. (OSCI)</title><copyright>Copyright © 2026 Knight Sac Media.  All rights reserved.</copyright><link>https://www.siliconinvestor.com/subject.aspx?subjectid=4633</link><description>
To all interested Biotech investors, please feel free to discuss GENE on this thread.  I will put together financial information and additional broker analysis on this stock as time progresses.  My broker said that the latest report from a firm that tracks this company projects a price of $25 in 12 months, currently trading at $10 (5/16/96).    This company works on genome research to identify and characterize genes involved in common diseases, and to translate the discoveries into therapeutic  breakthroughs.  GENE is a fast-growing and financially successful biotechnology company.  In the past year they have been awarded over US$10M by the NIH to develop  state-of-the-art DNA sequencing technology initiated a US$22M alliance with Astra AB to develop genome-based drugs and vaccines entered into a US$40M  research collaboration with Schering-Plough Corporation to discover novel anti-infective agents raised US$2.1M in a private capital placement and raised US$44M in a public stock offering  Good Luck Tara!!!   :)</description><image><url>https://www.siliconinvestor.com/images/Logo380x132.png</url><title>SI - Oscient Pharmaceuticals Corp. (OSCI)</title><link>https://www.siliconinvestor.com/subject.aspx?subjectid=4633</link><width>380</width><height>132</height></image><ttl>10</ttl></channel></rss>